Stockreport

Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts [Seeking Alpha]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF That is not too far away, but that doesn't mean that there aren't any near-term catalysts for investors to focus on. It is expected that initial data from the pediatric [Read more]